pregnancy. Anaemia complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention 1: control: daily dose of iron supplementation (50 mg/dose) from 20 weeks of gestation. Intervention 2: Case: 3 times of iron supplementation in week (50 mg/dose) from 20 weeks of gestati
Prevention
control: daily dose of iron supplementation (50 mg/dose) from 20 weeks of gestation
Case: 3 times of iron supplementation in week (50 mg/dose) from 20 weeks of gestation.
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
17 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Healthy pregnant women; Less than 20 weeks of gestation; More than 11 g% hemoglobin level. Exclusion criteria: People with ß minor thalassemia; Diagnosed internal diseases; Abortion; More than 2 delivery.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hb. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: coulter counter: g%.;MCV. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colter counter: fl.;RBC. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colter counter: mil/mm3.;Iron. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colorimetric: micg%.;Ferritin. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: ELISA: ng/ml.;Zinc. Timepoint: 20, 26-28 and 34-37 weeks of gestation. Method of measurement: colorimetric: micg%. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarahnaz Sadighian
Babol University of Medical Sciences
Outcome results
None listed